Article
Polymorphisms in the Osteoprotegerin Gene Are Associated With Osteoporotic Fractures
1 Jul 2002
Abstract excerpt
Osteoprotegerin (OPG) is a soluble receptor for RANKL and therefore a competitive inhibitor of osteoclast differentiation and activity. With this key role in the control of resorptive activity, we found that OPG is a candidate gene for genetic control of bone mass. We examined the promoter and the five exons with surrounding intron sequences of the OPG gene for polymorphisms in 50 normal patients and 50 patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
